Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of IOL Chemicals & Pharmaceuticals Ltd

About the Company - IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 29/09/1986 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24116PB1986PLC007030 and registration number is 007030. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2184.02 Cr. and Equity Capital is Rs. 58.71 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsVillage & Post Office Handiaya, Fatehgarh Channa Road, Barnala Punjab 148107investor@iolcp.com
http://www.iolcp.com
Management
NamePosition Held
Mr. Rajender Mohan MallaChairman & Ind.Director
Mr. Varinder GuptaManaging Director
Mr. Vikas GuptaJoint Managing Director
Mr. Kushal Kumar RanaDirector - Works
Dr.(Mrs.) Sandhya MehtaIndependent Director
Mr. Harpal SinghIndependent Director
Mr. Sharad TyagiIndependent Director
Mr. Abhiraj GuptaExecutive Director

Basic Stock Data of IOL Chemicals & Pharmaceuticals Ltd

Last Updated: June 20, 2024, 10:42 pm

Market Cap 2,473 Cr.
Current Price 421
High / Low536/331
Stock P/E18.3
Book Value 274
Dividend Yield1.19 %
ROCE12.3 %
ROE8.69 %
Face Value 10.0
PEG Ratio-1.29

Competitors of IOL Chemicals & Pharmaceuticals Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Vivimed Labs Ltd 41.0 Cr. 4.955.90/4.85 21.30.00 %51.5 %163 % 2.00
Aarti Pharmalabs Ltd 5,404 Cr. 596639/32024.9 1940.34 %16.6 %13.1 % 5.00
Beta Drugs Ltd 1,176 Cr. 1,2231,595/71532.3 1630.00 %36.0 %29.6 % 10.0
Checkpoint Trends Ltd 5.18 Cr. 9.4712.4/3.76173 0.970.00 %3.39 %5.83 % 10.0
Ami Organics Ltd 5,248 Cr. 1,3931,470/1,00488.2 1830.22 %16.0 %9.39 % 10.0
Industry Average15,442.61 Cr1,221.0638.61195.110.34%17.38%16.81%6.46

IOL Chemicals & Pharmaceuticals Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales513460519538555572565541523587563545520
Expenses356349408494496529509510480491490481476
Operating Profit15711111044594356324396736444
OPM %31%24%21%8%11%8%10%6%8%16%13%12%9%
Other Income86-811975579778
Interest1122223455444
Depreciation10101011111111111212141616
Profit before tax1541069042553747223388625132
Tax %25%29%25%26%27%24%25%28%27%25%25%26%28%
Net Profit115756731402835162465463823
EPS in Rs19.5612.8211.415.256.834.735.942.674.1111.127.876.443.96

Last Updated: June 6, 2024, 9:19 am

IOL Chemicals & Pharmaceuticals Ltd Quarterly Chart

IOL Chemicals & Pharmaceuticals Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales4714825643855807119831,6851,8941,9672,1842,2172,219
Expenses4023924683735296088631,2761,3211,3751,9271,9901,943
Operating Profit6989961151102120410574592257227276
OPM %15%18%17%3%9%14%12%24%30%30%12%10%12%
Other Income2311116101624172530
Interest435760596168645121681618
Depreciation24313229303030323639434654
Profit before tax435-75-39631336533571223189233
Tax %-25%46%35%12%-4%21%12%30%32%22%26%26%
Net Profit523-67-40528237361445166140173
EPS in Rs1.850.611.15-13.99-7.120.834.9341.6163.5175.7328.2223.8429.54
Dividend Payout %0%0%0%0%0%0%0%0%5%8%14%17%

IOL Chemicals & Pharmaceuticals Ltd Profit & Loss Yearly Chart

IOL Chemicals & Pharmaceuticals Ltd Growth

Compounded Sales Growth
10 Years:17%
5 Years:18%
3 Years:5%
TTM:1%
Compounded Profit Growth
10 Years:56%
5 Years:38%
3 Years:-27%
TTM:68%
Stock Price CAGR
10 Years:35%
5 Years:18%
3 Years:-13%
1 Year:-1%
Return on Equity
10 Years:22%
5 Years:28%
3 Years:20%
Last Year:10%

Last Updated: April 28, 2024, 9:25 pm

IOL Chemicals & Pharmaceuticals Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital26262948565656575759595959
Reserves1431421601541291321604087471,2021,3321,4481,530
Preference Capital5520000000000
Borrowings394400357400453447422284593448059
Other Liabilities124159195100135182214193306347526434432
Total Liabilities6877277417027728178529421,1701,6101,9602,0212,080
Fixed Assets462430411403400374406412469512561751855
CWIP123233442172719481059040
Investments000000000122020
Other Assets2132652972953694224395036821,0481,2921,1591,165
Total Assets6877277417027728178529421,1701,6101,9602,0212,080

IOL Chemicals & Pharmaceuticals Ltd Reserves and Borrowings Chart

IOL Chemicals & Pharmaceuticals Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 555378-47188312027347138091123
Cash from Investing Activity -87-18-12-5-27-23-50-63-184-317-121-119
Cash from Financing Activity 23-32-66509-60-70-197-272-58-2-4
Net Cash Flow-931-2-01-113154-31-0

IOL Chemicals & Pharmaceuticals Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days172732315558544352567983
Inventory Days1601991902792012011096664989577
Days Payable9711611992102115834262799574
Cash Conversion Cycle80110103218154144806755747986
Working Capital Days328258173125108735757667886
ROCE %9%11%11%-3%4%12%15%56%69%54%18%14%

IOL Chemicals & Pharmaceuticals Ltd Financial Efficiency Indicators Chart

IOL Chemicals & Pharmaceuticals Ltd Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters43.69%43.69%43.69%43.69%43.69%43.69%43.69%48.19%48.19%48.19%48.19%48.19%
FIIs5.05%2.76%3.03%3.14%2.50%2.41%2.37%2.43%3.54%2.33%2.18%1.40%
DIIs0.04%0.36%0.51%0.04%0.04%0.05%0.16%0.23%0.25%0.35%0.36%0.29%
Public51.21%53.18%52.77%53.13%53.77%53.84%53.78%49.15%48.02%49.12%49.27%50.11%
No. of Shareholders1,27,8931,42,0221,45,0411,46,4371,48,9071,45,6921,43,3271,40,1771,26,0041,35,3971,34,2351,30,003

IOL Chemicals & Pharmaceuticals Ltd Shareholding Pattern Chart

No. of IOL Chemicals & Pharmaceuticals Ltd Shareholders

IOL Chemicals & Pharmaceuticals Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal Nifty Microcap 250 Index Fund25,3420.21.1525,3422024-06-170%
Motilal Oswal S&P BSE Healthcare ETF2430.120.0125,3422024-06-17-99.04%
Groww Nifty Total Market Index Fund650.01025,3422024-06-17-99.74%

IOL Chemicals & Pharmaceuticals Ltd ROCE Trend

IOL Chemicals & Pharmaceuticals Ltd EPS Trend

IOL Chemicals & Pharmaceuticals Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22
FaceValue10.0010.0010.00
Basic EPS (Rs.)22.9023.7028.56
Diluted EPS (Rs.)22.9023.7028.56
Cash EPS (Rs.)33.6131.5635.93
Book Value[Excl.RevalReserv]/Share (Rs.)274.49256.81237.15
Book Value[Incl.RevalReserv]/Share (Rs.)274.49256.81237.15
Revenue From Operations / Share (Rs.)363.27377.64372.00
PBDIT / Share (Rs.)44.4042.8049.45
PBIT / Share (Rs.)33.6834.9442.08
PBT / Share (Rs.)30.9432.1338.30
Net Profit / Share (Rs.)22.9023.7028.56
NP After MI And SOA / Share (Rs.)22.9023.7028.56
PBDIT Margin (%)12.2211.3313.29
PBIT Margin (%)9.279.2511.31
PBT Margin (%)8.518.5010.29
Net Profit Margin (%)6.306.277.67
NP After MI And SOA Margin (%)6.306.277.67
Return on Networth / Equity (%)8.349.2212.04
Return on Capital Employeed (%)11.7413.0917.05
Return On Assets (%)5.986.888.54
Total Debt / Equity (X)0.020.050.03
Asset Turnover Ratio (%)0.991.110.00
Current Ratio (X)2.002.022.11
Quick Ratio (X)1.241.301.31
Inventory Turnover Ratio (X)3.824.180.00
Dividend Payout Ratio (NP) (%)0.0016.8821.00
Dividend Payout Ratio (CP) (%)0.0012.6816.69
Earning Retention Ratio (%)0.0083.1279.00
Cash Earning Retention Ratio (%)0.0087.3283.31
Interest Coverage Ratio (X)16.1915.2635.02
Interest Coverage Ratio (Post Tax) (X)9.359.4522.91
Enterprise Value (Cr.)2012.241718.711979.92
EV / Net Operating Revenue (X)0.940.770.90
EV / EBITDA (X)7.726.846.82
MarketCap / Net Operating Revenue (X)0.990.740.95
Retention Ratios (%)0.0083.1178.99
Price / BV (X)1.321.101.49
Price / Net Operating Revenue (X)0.990.740.95
EarningsYield0.060.080.08

IOL Chemicals & Pharmaceuticals Ltd Profitability Ratios (%)

IOL Chemicals & Pharmaceuticals Ltd Liquidity Ratios

IOL Chemicals & Pharmaceuticals Ltd Liquidity Ratios (%)

IOL Chemicals & Pharmaceuticals Ltd Interest Coverage Ratios (%)

IOL Chemicals & Pharmaceuticals Ltd Valuation Ratios

Fair Value

Fair Value: 440.92

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 4.73% compared to the current price 421

Intrinsic Value: 378.33

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Overvalued: 10.13% compared to the current price ₹421

Last 5 Year EPS CAGR: -14.19%

*Investments are subject to market risks

Strength and Weakness of IOL Chemicals & Pharmaceuticals Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 22.50%, which is a positive sign.
  2. The company has higher reserves (591.31 cr) compared to borrowings (2.31 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (321.92 cr) and profit (155.38 cr) over the years.
  1. The stock has a high average Working Capital Days of 82.92, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 104.17, which may not be favorable.

FAQ

What is the latest fair value of IOL Chemicals & Pharmaceuticals Ltd?

The latest fair value of IOL Chemicals & Pharmaceuticals Ltd is ₹440.92.

What is the Market Cap of IOL Chemicals & Pharmaceuticals Ltd?

The Market Cap of IOL Chemicals & Pharmaceuticals Ltd is 2,473 Cr..

What is the current Stock Price of IOL Chemicals & Pharmaceuticals Ltd as on 21 June 2024?

The current stock price of IOL Chemicals & Pharmaceuticals Ltd as on 21 June 2024 is ₹421.

What is the High / Low of IOL Chemicals & Pharmaceuticals Ltd stocks in FY 2024?

In FY 2024, the High / Low of IOL Chemicals & Pharmaceuticals Ltd stocks is 536/331.

What is the Stock P/E of IOL Chemicals & Pharmaceuticals Ltd?

The Stock P/E of IOL Chemicals & Pharmaceuticals Ltd is 18.3.

What is the Book Value of IOL Chemicals & Pharmaceuticals Ltd?

The Book Value of IOL Chemicals & Pharmaceuticals Ltd is 274.

What is the Dividend Yield of IOL Chemicals & Pharmaceuticals Ltd?

The Dividend Yield of IOL Chemicals & Pharmaceuticals Ltd is 1.19 %.

What is the ROCE of IOL Chemicals & Pharmaceuticals Ltd?

The ROCE of IOL Chemicals & Pharmaceuticals Ltd is 12.3 %.

What is the ROE of IOL Chemicals & Pharmaceuticals Ltd?

The ROE of IOL Chemicals & Pharmaceuticals Ltd is 8.69 %.

What is the Face Value of IOL Chemicals & Pharmaceuticals Ltd?

The Face Value of IOL Chemicals & Pharmaceuticals Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in IOL Chemicals & Pharmaceuticals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE